Publications by authors named "Yongyu Yang"

Claim this Profile
S
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter Study.
Da-Long Yang, Ning Peng, Jun-Liang Nong, Kang Chen, Ze Su, Fu-Quan Yang, Yong-Yu Yang

Liver Cancer· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of radiological and pathological complete response following immune-based conversion therapy in patients with unresectable hepatocellular carcinoma (GUIDANCE004).
Da-Long Yang, Yi-He Yan, Yong-Cheng Lai, Ming-Song Wu, Xiao-Feng Dong, Fu-Quan Yang, Yong-Yu Yang

JHEP Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TBA-MLR score: a metabolic-immune prognostic biomarker for postoperative hepatocellular carcinoma.
Yuanquan Zhao, Wei Huang, Xiwen Deng, Pengyang Li, Siyang Yao, Yongyu Yang

Front Immunol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages.
Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Fu-Quan Yang, Yong-Yu Yang

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Multicenter, retrospective GUIDANCE001 study comparing transarterial chemoembolization with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stages.
Da-Long Yang, Lin Ye, Fan-Jian Zeng, Jie Liu, Hong-Bing Yao, Fu-Quan Yang, Yong-Yu Yang

Hepatology· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New advances in novel pharmacotherapeutic candidates for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) between 2022 and 2024.
Shu Wei Wong, Yong-Yu Yang, Hui Chen, Li Xie, Xi-Zhong Shen

Acta Pharmacol Sin· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppressing MASH fibrotic progression by blocking succinate-GPR91 signaling in HSCs.
Li Xie, Hui Chen, Li Zhang, Yong-Yu Yang, Yuan Zhou

Hepatology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shenfushu granules attenuate diabetic kidney disease by inhibiting /protein kinase B/heparanase-mediated endothelial-mesenchymal transition.
Xi-Ding Yang, Si-Jia Ma, Da-Xiong Xiang, Yong-Yu Yang

World J Diabetes· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of thymosin alpha-1 combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a retrospective study.
Siyang Yao, Qiangsong Huang, Yan Zou, Tianqi Liu, Yongyu Yang

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manshenkang granules alleviate fibrosis in chronic renal failure rats by regulating the PDE4b/cAMP pathway.
Yong-Yu Yang, Nian-Chun Gong, Yan-Mei Peng, Zhou-Sheng Yang, Da-Xiong Xiang

J Ethnopharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of problem-based learning for pharmacology based on a comprehensive analysis in undergraduate students.
Xiding Yang, Zehua Yang, Sijia Ma, Miao Yan, Yongyu Yang

Medicine (Baltimore)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response.
Xiayi Liang, Duo Wang, Yuanquan Zhao, Xiaobo Wang, Siyang Yao, Yongyu Yang, Jianrong Yang

J Nanobiotechnology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis.
Xiding Yang, Qiangyong Yan, Lingfeng Yang, Jingjing Li, Xiao Fan, Yongyu Yang

Eur J Clin Pharmacol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case report of autosomal dominant deafness type 2A potentially resulting in muscular dystrophy.
Yongyu Yang, Meilian Wang, Yan Lu, Jinliang Wu

Asian J Surg· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Pharmacokinetics of Semaglutide: A Systematic Review.
Xi-Ding Yang, Yong-Yu Yang

Drug Des Devel Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic changes of gut microbiota in mouse models of metabolic dysfunction-associated steatohepatitis and its transition to hepatocellular carcinoma.
Yu-Li Wang, Chang Liu, Yong-Yu Yang, Li Zhang, Xiao Guo

FASEB J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Construction and application of medication reminder system: intelligent generation of universal medication schedule.
Hangxing Huang, Lu Zhang, Yongyu Yang, Ling Huang, Xikui Lu, Jingyang Li

BioData Min· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic artery pseudoaneurysm: three case reports and literature review.
Yuan-Quan Zhao, Yong-Yu Yang, Si-Yang Yao, Xiao-Feng Dong

Front Med (Lausanne)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Naodesheng Pills Ameliorate Cerebral Ischemia Reperfusion-Induced Ferroptosis via Inhibition of the ERK1/2 Signaling Pathway.
Yong-Yu Yang, Rong-Rong Deng, Da-Xiong Xiang

Drug Des Devel Ther· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis.
Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Qiang Yang

Clin Mol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGF-β1/SMAD3-driven GLI2 isoform expression contributes to aggressive phenotypes of hepatocellular carcinoma.
Jia Ding, Yong-Yu Yang, Peng-Tao Li, Yue Ma, Li Zhang

Cancer Lett· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Both liver parenchymal and non-parenchymal cells express JCAD protein under various circumstances.
Li Xie, Li Zhang, Hui Chen, Yong-Yu Yang, Jian Wu

Clin Mol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway.
Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong

Clin Transl Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esculin ameliorates obesity-induced insulin resistance by improving adipose tissue remodeling and activating the IRS1/PI3K/AKT/GLUT4 pathway.
Yong-Yu Yang, Jing-Jing Qi, Si-Yi Jiang, Ling Ye

J Ethnopharmacol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secretome of senescent hepatic stellate cells favors malignant transformation from nonalcoholic steatohepatitis-fibrotic progression to hepatocellular carcinoma.
Yuan Zhou, Li Zhang, Yue Ma, Li Xie, Yong-Yu Yang

Theranostics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis